Overall, 58% of evaluable patients treated with the therapeutic dose of VB-111 had a GCIG CA-125
At follow-up visits, a physical examination, ultrasonography, complete blood count, and blood chemistry including serum CA-125
level were performed.
is a high-molecular weight glycoprotein that is expressed at the cell-surface of epithelial cells.
is the most frequently used biomarker for ovarian cancer detection.
Objective: To determine the association of CA-125
levels with the peritoneal dissemination among the patients of colo-rectal carcinoma at a tertiary care surgical oncology unit of Pakistan
levels were determined in 221 patients, of whom elevated CA-125
levels (>35 U/ml) were found in 160 (72.4%) patients, while the median CA-125
level was 65.9 U/ml (range, 7.3-1227.0 U/ml).
* Screening (such as transvaginal ultrasound and/or a tumor marker, CA-125
blood test) does not reduce the mortality due to ovarian cancer.
level was 29.62 IU/ml (in normal range).
A blood test can be carried out to identify a blood protein that is elevated in many cases of ovarian cancer, called CA-125
The screening methods used in the trials included transvaginal ultrasound alone, CA-125
testing alone, and transvaginal ultrasound plus CA-125
Serum concentration of CA-125
during the first trimester of normal and abnormal pregnancies.
Tenders are invited for BarMT 97 / 18-P - reagents and consumables for the automatic biochemical analyzer BA 400; reagents for enzyme immunoassay (ELISA test system CA-125